Publications by authors named "John Gooya"

Claim this Profile
E
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.
Jeong-Won Lee, Rebecca L Stone, Sun Joo Lee, Eun Ji Nam, Ju-Won Roh, John Gooya

Clin Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Jeong-Won Lee, Hee Dong Han, Mian M K Shahzad, Seung Wook Kim, Lingegowda S Mangala, John Gooya

J Natl Cancer Inst· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche.
Hyung Chan Suh, Ming Ji, John Gooya, Michael Lee, Kimberly D Klarmann

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib.
Ching Ching Leow, Jon Chesebrough, Karen T Coffman, Christine A Fazenbaker, John Gooya

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Dowdy Jackson, John Gooya, Shenlan Mao, Krista Kinneer, Linda Xu

Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development.
Tao Fan, Anja Schmidtmann, Sichuan Xi, Victorino Briones, Heming Zhu, John Gooya

Epigenetics· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.
Cyril Berthet, Maria Cecilia Rodriguez-Galan, Deborah L Hodge, John Gooya, Véronique Pascal

Mol Cell Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.
Hyung Chan Suh, John Gooya, Katie Renn, Alan D Friedman, Peter F Johnson

Blood· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development.
Wilairat Leeanansaksiri, Hui Wang, John M Gooya, Katie Renn, Mehrnoosh Abshari

J Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of growth by p205: a nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation.
Jonathan M Dermott, John M Gooya, Benyam Asefa, Sarah R Weiler, Mark Smith

Stem Cells· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo.
Victoria Heath, Hyung Chan Suh, Matthew Holman, Katie Renn, John M Gooya

Blood· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis